News | February 27, 2025
Senores Pharmaceuticals begins operations at greenfield API facility
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
The observations issued are neither repeated observations nor related to data integrity
The Alathur facility specializes in the production of Cephalosporin antibiotics
Based on DESTINY-Breast06 Phase III trial results which showed Enhertu demonstrated superiority vs. chemotherapy with a median progression-free survival of more than one year
Teriflunomide is a novel disease-modifying agent that was approved for use in the treatment of multiple sclerosis
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders
The company has paid an Interim Environmental Damage Compensation of Rs. 3.40 lakh to GPCB
The company ensures a reliable and strong portfolio at competitive prices without compromising on excellent quality
Investment will fund expansion to meet rising demand for CRDMO services
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
Subscribe To Our Newsletter & Stay Updated
